Corpus Intelligence IC Memo — PARKLAND HEALTH CENTER - FARMINGTON 2026-04-26 19:06 UTC
IC Memo — PARKLAND HEALTH CENTER - FARMINGTON
Investment Committee Memorandum | MO | 108 beds | Grade C | EBITDA uplift $9.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

PARKLAND HEALTH CENTER - FARMINGTON

CCN 260163 | nan, MO | 108 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

PARKLAND HEALTH CENTER - FARMINGTON is a 108-bed suburban community hospital in nan, MO with $124.2M in net patient revenue and a 8.6% operating margin. The hospital serves a payer mix of 34.0% Medicare, 10.7% Medicaid, and 55.4% commercial.

Thesis: Turnaround. Our ML models identify $9.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 8.6% to 16.0% (+736bps).

Net Revenue HCRIS$124.2M
Current EBITDA COMPUTED$10.7M
Operating Margin COMPUTED8.6%
Occupancy HCRIS46.3%
Revenue / Bed COMPUTED$1.2M
Net-to-Gross HCRIS26.1%
Distress Probability ML50.6%

2. Market Context & Competitive Position

138
MO Hospitals
-6.2%
State Median Margin
39
Comparable Hospitals

MO has 138 Medicare-certified hospitals with a median operating margin of -6.2%. The target's margin of 8.6% places it above the state median. Among 39 size-comparable peers (54-216 beds), the median margin is -0.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (54-216), prioritizing same-state peers. 39 hospitals in the comp set.

HospitalStateBedsRevenueMargin
PARKLAND HEALTH CENTER - FARMI (Target)MO108$124.2M8.6%
ST. LUKES EAST - LEES SUMMITMO216$318.1M-5.8%
LIBERTY HOSPITALMO199$303.2M-3.1%
PHELPS COUNTY REGIONAL MEDICALMO196$270.3M33.1%
LAKE REGIONAL HEALTH SYSTEMMO105$226.8M-2.7%
HANNIBAL REGIONAL HOSPITALMO86$226.2M-6.8%
SSM HEALTH ST CLARE HOSPITALMO180$225.5M2.8%
CAPITAL REGION MEDICAL CENTERMO100$224.0M-17.7%
BARNES JEWISH WEST COUNTY HOSPMO68$221.1M4.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $9.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$2.6M+210bp18mo
Cost to Collect4.5%2.5%$2.5M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.5M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.5M+122bp9mo
Clean Claim Rate88.0%96.0%$79K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$2.6M
Cost to Collect
$2.5M
Denial Rate Reduction
$2.5M
A/R Days Reduction
$1.5M
Clean Claim Rate
$79K
Total EBITDA Uplift$9.1M
Current EBITDA$10.7M
+ RCM Uplift+$9.1M
Pro Forma EBITDA$19.9M
Current Margin8.6%
Pro Forma Margin16.0%
WC Released (1x)$4.8M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$16.5M$162.1M9.84x58.0%
Base (11x exit)10.0x11.0x$16.5M$183.7M11.14x62.0%
Bull Case9.0x11.0x$14.8M$219.2M14.78x71.4%
Bull (12x exit)9.0x12.0x$14.8M$243.5M16.42x75.0%
Bear Case11.0x10.0x$18.1M$111.0M6.12x43.7%
Bear (11x exit)11.0x11.0x$18.1M$128.0M7.06x47.8%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighElevated distress probabilityModel estimates 50.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 39 hospitals with 54-216 beds
  • Same-state prioritization (n=40)
  • Comp margins: P25=-9.2% / P50=-0.8% / P75=12.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.